Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|February 13, 2023
Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancerLiang Zheng, Anning Xiong, Shuyuan Wang, et al.
Diabetes, Obesity & Metabolism|June 11, 2026
Abnormal Glycaemic Fluctuations Associated With Early Microvascular Changes in the Retina and Choroid of Nondiabetic AdultsYan Jiang, Liping Gu, Yuhang Ma, et al.
Cancer Medicine|September 11, 2024
The prognosis and metabolite changes of NSCLC patients receiving first-line immunotherapy combined chemotherapy in different M1c categories according to 9th edition of TNM classificationLiang Zheng, Fang Hu, Wei Nie, et al.
Cell Death & Disease|August 26, 2021
hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527Changhui Li, Jiaqi Zhang, Xiaohua Yang, et al.
Translational Lung Cancer Research|March 4, 2022
Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective studyHuiping Qiang, Yuqiong Lei, Yinchen Shen, et al.
Translational Vision Science & Technology|February 18, 2026
DiFFA: A Diffusion-Based Model for Synthetic Fundus Fluorescein Angiography to Enhance Detection of Diabetic Microvascular ComplicationJin Wei, Yupeng Xu, Tian Niu, et al.
Journal for Immunotherapy of Cancer|April 19, 2024
Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancerLiang Zheng, Fang Hu, Lin Huang, et al.
Frontiers in Immunology|April 17, 2025
Metabolomic machine learning-based model predicts efficacy of chemoimmunotherapy for advanced lung squamous cell carcinomaLiang Zheng, Wei Nie, Shuyuan Wang, et al.
American Journal of Ophthalmology|August 28, 2018
Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX StudyKun Liu, Yanping Song, Gezhi Xu, et al.
Translational Lung Cancer Research|August 12, 2022
Efficacy and safety of first-line anlotinib-based combinations for advanced non-small cell lung cancer: a three-armed prospective studyTianqing Chu, Wei Zhang, Bo Zhang, et al.
Pageof 8